Takao Y - Search Results

1

Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.

Kumashiro R, Koga Y, Kuwahara R, Ide T, Hino T, Tanaka K, Hisamochi A, Ogata K, Takao Y, Koga H, Nishida H, Okuda S, Sakamoto T, Sata M. Kumashiro R, et al. Among authors: takao y. Hepatol Res. 2006 Nov;36(3):229-36. doi: 10.1016/j.hepres.2006.06.016. Epub 2006 Sep 1. Hepatol Res. 2006. PMID: 16949861

2

Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.

Tamura M, Yamada A, Takao Y, Matsueda S, Komatsu N, Yutani S, Ide T, Sata M, Itoh K. Tamura M, et al. Among authors: takao y. Hepatol Res. 2005 Aug;32(4):227-34. doi: 10.1016/j.hepres.2005.06.003. Epub 2005 Aug 10. Hepatol Res. 2005. PMID: 16095964

3

Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients.

Takao Y, Yamada A, Yutani S, Takedatsu H, Ono T, Etoh K, Wang Y, Suzuki S, Ide T, Shimotohno K, Sata M, Itoh K. Takao Y, et al. Hepatol Res. 2007 Mar;37(3):186-95. doi: 10.1111/j.1872-034X.2007.00018.x. Hepatol Res. 2007. PMID: 17362301

4

Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.

Kuwahara R, Kumashiro R, Ide T, Koga Y, Hino T, Hisamochi A, Tanaka K, Ogata K, Koga H, Takao Y, Sata M. Kuwahara R, et al. Among authors: takao y. Dig Dis Sci. 2008 Nov;53(11):2999-3006. doi: 10.1007/s10620-008-0384-x. Epub 2008 Jul 10. Dig Dis Sci. 2008. PMID: 18618250

5

Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.

Yutani S, Yamada A, Yoshida K, Takao Y, Tamura M, Komatsu N, Ide T, Tanaka M, Sata M, Itoh K. Yutani S, et al. Among authors: takao y. Vaccine. 2007 Oct 16;25(42):7429-35. doi: 10.1016/j.vaccine.2007.08.005. Epub 2007 Aug 24. Vaccine. 2007. PMID: 17845828 Clinical Trial.

6

A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.

Matsueda S, Yamada A, Takao Y, Tamura M, Komatsu N, Yutani S, Ide T, Sata M, Itoh K. Matsueda S, et al. Among authors: takao y. Cancer Immunol Immunother. 2007 Sep;56(9):1359-66. doi: 10.1007/s00262-007-0284-5. Epub 2007 Jan 31. Cancer Immunol Immunother. 2007. PMID: 17265020 Free PMC article.

7

Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.

Takao Y, Yamada A, Yutani S, Ono T, Nagao Y, Ando E, Ide T, Itoh K, Sata M. Takao Y, et al. Med Microbiol Immunol. 2007 Sep;196(3):157-64. doi: 10.1007/s00430-007-0038-1. Epub 2007 Feb 16. Med Microbiol Immunol. 2007. PMID: 17574493

8

New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.

Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A. Wang Y, et al. Among authors: takao y. Microbiol Immunol. 2006;50(11):857-65. doi: 10.1111/j.1348-0421.2006.tb03861.x. Microbiol Immunol. 2006. PMID: 17116980 Free article.

9

Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction.

Takao Y, Yamada A, Yutani S, Sata M, Itoh K. Takao Y, et al. Microbiol Immunol. 2004;48(7):507-17. doi: 10.1111/j.1348-0421.2004.tb03546.x. Microbiol Immunol. 2004. PMID: 15272196 Free article.

10

Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.

Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh K, Yamada A. Wang Y, et al. Among authors: takao y. Cell Immunol. 2006 May;241(1):38-46. doi: 10.1016/j.cellimm.2006.07.009. Epub 2006 Sep 11. Cell Immunol. 2006. PMID: 16963008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page